Observational × Carcinoma, Hepatocellular × 30 days × Clear all CHANCE2202
Completed
941 enrolled
CHANCE2201
Completed
1,244 enrolled
CHALNA2
Recruiting
710 enrolled
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
Recruiting
100 enrolled
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Active not recruiting
132 enrolled
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Suspended
2,400 enrolled
TraveraRTGx
Completed
72 enrolled
Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes
Active not recruiting
76 enrolled
Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
Active not recruiting
1,523 enrolled
ISTAR-01
Recruiting
138 enrolled
ISTAR-02
Recruiting
146 enrolled
ELUCIDATE
Recruiting
400 enrolled
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Recruiting
5,000 enrolled
VOCAL
Completed
56 enrolled
Optimizing Y90 Therapy for Radiation Lobectomy
Recruiting
104 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
Not yet recruiting
400 enrolled
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
Completed
1 enrolled
CCGLC-019
Not yet recruiting
162 enrolled
Treat Primary and Metastatic Liver Tumors
Withdrawn
cfDNA Methylation for Liver Cancer Recurrence Detection
Recruiting
500 enrolled
Evaluation of Resection Techniques for Pancreatic Tumors
Recruiting
431 enrolled
QUS in HCC
Recruiting
328 enrolled
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Recruiting
300 enrolled